Clinical Trials in Boston

Showing 12441-12460 of 15,299 trials

Automated Tele Counseling for Screening Mammography

NCT00247013

The purpose and aim of this study is to test the use of a computer-based, automated telecommunications system and its effectiveness in increasing the rates of regular screening mammography among women ages 50-74. The system will not only help in scheduling appointments but will help women in overcoming any barriers that may deter them from having the procedure at all. The programs are designed to be user friendly and easy to implement in clinical practice.

Breast Cancer

Boston Medical Center2,120 participantsStarted Jan 1996

Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

GORE Flow Reversal System and GORE Embolic Filter Extension Study

NCT01343667

The objective of this study is to provide an ongoing evaluation of clinical outcomes associated with the GORE Flow Reversal System and the GORE Embolic Filter when used for embolic protection during carotid artery stenting.

Carotid StenosisConstriction, PathologicCarotid Artery Diseases+8 more

W.L.Gore & Associates1,397 participantsStarted Apr 2011

Flagstaff, Arizona, United States • Newport Beach, California, United States • San Francisco, California, United States +36 more locations

Automated Tele Counseling for Screening Mammography

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Find Trials by Condition in Boston

Blood and Marrow Transplant Clinical Research Network

Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer

Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

Tai Chi and Aerobic Exercise for Fibromyalgia (FMEx)

Does Weight Loss Surgery and Probiotic Supplementation Lead to a "Lean" Gut Microbiota?

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

A Novel Diet-Phenotype Interaction Affecting Body Weight

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

Atacicept in Subjects With Optic Neuritis

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Safety of Gadovist in Renally Impaired Patients

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide

Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU

Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia